Therefore, inhibiting NLRP3 inflammasome activation, suppressing GSDMD cleavage or membrane pore formation, and modulating miRNA levels could serve as effective strategies to inhibit OSA-related pyroptosis. The gene discussed is GSDMD; the disease is obstructive sleep apnea syndrome.